Literature DB >> 26615405

The public debate on psychotropic medication and changes in attitudes 1990-2011.

Matthias C Angermeyer1,2, Sandra Van der Auwera3, Herbert Matschinger4,5, Mauro G Carta6, Sebastian E Baumeister7, Georg Schomerus3,8.   

Abstract

Over the last 25 years, the appraisal of psychotropic drugs within the scientific community and their representation in the media has changed considerably. The initial optimism in the wake of the introduction of second-generation drugs has increasingly made room for a more critical evaluation of alleged advantages of these drugs. The question arises as to what extent this is reflected in similar changes in the public's attitudes towards psychiatric medication. Three representative population surveys on attitudes towards psychotropic medication were carried out in Germany in 1990 (N = 3075), 2001 (N = 2610) and 2011 (N = 1223), using the same sampling procedure, interview mode and instrument for assessing attitudes. In order to disentangle time-related effects, an age-period-cohort analysis was performed. Over the time period of 21 years, the German public's evaluation of psychotropic medication has become markedly more favourable. This change was mostly due to a period effect, i.e. concurrent influences of the social environment people are exposed to. Changes were much more pronounced in the 1990s, while over the following decade only a small, although statistically significant, increase in the favourable appraisal of medication was found. Age and birth cohort had only a minor effect on public attitudes. Our findings suggest that changes in the evaluation of the effects of psychotropic drugs within the psychiatric community and their representation in the media also affect public opinion. Given the ongoing debate about side effects and efficacy of psychiatric medication, future changes of public opinion can be expected.

Entities:  

Keywords:  Attitudes; Population study; Psychotropic medication; Time trend

Mesh:

Substances:

Year:  2015        PMID: 26615405     DOI: 10.1007/s00406-015-0660-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  25 in total

1.  Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008.

Authors:  Hans Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11-19       Impact factor: 5.270

2.  Recommendations of the Sardinian public for the treatment of depression.

Authors:  Mauro G Carta; Matthias C Angermeyer; Herbert Matschinger; Anita Holzinger; Elisa Pintus; Mirra Pintus; Maria F Moro
Journal:  Int J Soc Psychiatry       Date:  2013-11-11

3.  Second-generation antipsychotics: a therapeutic downturn?

Authors:  Shôn Lewis
Journal:  Psychol Med       Date:  2009-10       Impact factor: 7.723

4.  The Australian public's beliefs about the harmfulness of antipsychotics: associated factors and change over 16 years.

Authors:  Nicola J Reavley; Stefan Cvetkovski; Anthony F Jorm
Journal:  Psychiatry Res       Date:  2012-10-27       Impact factor: 3.222

5.  Mass media representations as drug information for patients: the prozac phenomenon.

Authors:  M Montagne
Journal:  Subst Use Misuse       Date:  2001 Jul-Aug       Impact factor: 2.164

6.  Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany.

Authors:  M C Angermeyer; R Däumer; H Matschinger
Journal:  Pharmacopsychiatry       Date:  1993-07       Impact factor: 5.788

7.  Public attitudes towards the acceptability of using drugs to treat depression and ADHD.

Authors:  Brad Partridge; Jayne Lucke; Wayne Hall
Journal:  Aust N Z J Psychiatry       Date:  2012-06-11       Impact factor: 5.744

8.  Lay beliefs about causes of depression.

Authors:  C Lauber; L Falcato; C Nordt; W Rössler
Journal:  Acta Psychiatr Scand Suppl       Date:  2003

Review 9.  Second-generation antipsychotics for schizophrenia: can we resolve the conflict?

Authors:  S Leucht; W Kissling; J M Davis
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

10.  Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Authors:  Joanna Le Noury; John M Nardo; David Healy; Jon Jureidini; Melissa Raven; Catalin Tufanaru; Elia Abi-Jaoude
Journal:  BMJ       Date:  2015-09-16
View more
  1 in total

1.  Perceptions and Attitudes of Correctional Staff Toward ADHD-A Challenging Disorder in Everyday Prison Life.

Authors:  Anna Buadze; Nadine Friedl; Roman Schleifer; Susan Young; Andres Schneeberger; Michael Liebrenz
Journal:  Front Psychiatry       Date:  2021-01-28       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.